Most competitive data is spend-based. Brands lack real-time visibility into competitor creative pivots, messaging evolution, and unified share of voice.
Marketers struggle to link media spend to actual behavior. Traditional measurement relies on proxy metrics rather than verified exposure, leaving ROI unproven.
6 With customers increasingly using AI (ChatGPT, Google AI) for medical research, brands have zero visibility into how they are represented in these responses.
Most competitive data is spend-based. Brands lack real-time visibility into competitor creative pivots, messaging evolution, and unified share of voice.
Digital Tracker
Real-Time Digital & Omnichannel Intelligence
Capture verified HCP and patient digital behavior across all channels - banner ads, paid search, email, Med AI, and healthcare browsing. See exactly what competitors are saying and showing with actual creative access.
What You'll Track:
- Paid Search: Search queries, competitor ad copy, keyword triggers, and landing pages.
- Banner Ads: Endemic and non-endemic display (static and video creative).
- Email Marketing: Manufacturer, rep, and third-party communications.
- Med AI: Google AI Overviews, ChatGPT responses, and medical AI interactions.
- Healthcare Browsing: All website visits, content consumption, and time-on-site.
TV Tracker
Patient-Verified Linear & CTV Measurement
Verify which patients actually see your TV ads across linear and all streaming platforms. Get person-level share of voice (SOV) and targeting efficiency metrics that household-level ratings
can’t provide.
What You'll Track:
- Linear & Connected TV (CTV): All broadcast, cable, and streaming (Netflix, Hulu, Disney+, etc.).
- Audio Fingerprinting: Real-time identification of ad exposures via passive mobile capture.
- Targeting Efficiency: Analytics to identify channels that reach patients over general viewers.
- Unified SOV: Combined share of voice across traditional and digital TV.
|
ZoomRx
|
|
|
|
|---|---|---|---|
| Data Fidelity | Verified Patient-Level Exposure | Household/Population Ratings | Modeled/Probabilistic Inference |
| Channel Coverage | Omnichannel (TV + Digital + AI) | Siloed (Mainly TV) | Siloed (Mainly Digital/Claims) |
| Competitive Intel | Actual Creative & Messaging | Spend-based only | Limited/No Creative Access |
| Reporting Speed |
Bi-weekly Insights
|
8–12 Week Reporting Lag
|
Monthly/Quarterly Lag |
| Med AI Coverage | Yes (Industry First) | No | No |
| Methodology | Passive Observation | Panel-based inference |
Pixel-based tracking
|
.png?width=34&height=34&name=Group%2040648%20(1).png){kind=small}
.png?width=34&height=34&name=Group%2040649%20(1).png){kind=small}
Every participant is a confirmed HCP or patient. This ensures 100% targeting efficiency validation versus population-level panels where target patients are a tiny fraction of the sample.
Technology
Using browser extensions for digital and audio fingerprinting for TV, we capture authentic behavior without the burden of manual diaries or logging.
PHASE 1 (Observational)
Passive capture of real exposures and competitive landscape.
Surveys among the same panelists measure ad recall, brand lift, and intent to act.
Capture competitors' actual creative—email copy, banner ads, and TV commercials. Identify their platform strategies and messaging shifts in real-time.
Ready to Move Beyond Proxy Metrics and Aggregate Data?
Stop relying on algorithmic inference and retrospective reporting. Media Tracking delivers verified patient exposures, competitive intelligence, and real-time optimization for pharmaceutical marketing teams who need defensible ROI proof—not just impression counts.